vs

CB Financial Services, Inc.(CBFV)与ROCKWELL MEDICAL, INC.(RMTI)财务数据对比。点击上方公司名可切换其他公司

ROCKWELL MEDICAL, INC.的季度营收约是CB Financial Services, Inc.的1.3倍($18.3M vs $13.8M),CB Financial Services, Inc.同比增速更快(19.9% vs -25.6%),CB Financial Services, Inc.自由现金流更多($17.2M vs $2.2M),过去两年CB Financial Services, Inc.的营收复合增速更高(1.2% vs -10.1%)

CB银行是缅甸规模最大的商业银行之一,也是缅甸首家发行ATM卡与信用卡的银行。该银行由吴钦貌艾担任董事长、吴觉杜哥担任首席执行官,在缅甸全国拥有超过245家分支机构,是缅甸本土市场布局广泛的主流金融机构。

罗克韦尔医疗成立于1996年,总部位于美国密歇根州威克瑟姆,是一家上市制药企业,核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。

CBFV vs RMTI — 直观对比

营收规模更大
RMTI
RMTI
是对方的1.3倍
RMTI
$18.3M
$13.8M
CBFV
营收增速更快
CBFV
CBFV
高出45.5%
CBFV
19.9%
-25.6%
RMTI
自由现金流更多
CBFV
CBFV
多$15.0M
CBFV
$17.2M
$2.2M
RMTI
两年增速更快
CBFV
CBFV
近两年复合增速
CBFV
1.2%
-10.1%
RMTI

损益表 — Q4 FY2025 vs Q4 FY2025

指标
CBFV
CBFV
RMTI
RMTI
营收
$13.8M
$18.3M
净利润
$-554.0K
毛利率
21.1%
营业利润率
38.1%
-2.2%
净利率
-3.0%
营收同比
19.9%
-25.6%
净利润同比
26.7%
每股收益(稀释后)
$0.90
$-0.01

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
CBFV
CBFV
RMTI
RMTI
Q4 25
$13.8M
$18.3M
Q3 25
$2.4M
$15.9M
Q2 25
$13.5M
$16.1M
Q1 25
$12.1M
$18.9M
Q4 24
$13.2M
$24.7M
Q3 24
$12.7M
$28.3M
Q2 24
$12.2M
$25.8M
Q1 24
$13.5M
$22.7M
净利润
CBFV
CBFV
RMTI
RMTI
Q4 25
$-554.0K
Q3 25
$-5.7M
$-1.8M
Q2 25
$3.9M
$-1.5M
Q1 25
$1.9M
$-1.5M
Q4 24
$-756.0K
Q3 24
$3.2M
$1.7M
Q2 24
$2.6M
$343.0K
Q1 24
$4.2M
$-1.7M
毛利率
CBFV
CBFV
RMTI
RMTI
Q4 25
21.1%
Q3 25
14.3%
Q2 25
15.6%
Q1 25
16.1%
Q4 24
14.7%
Q3 24
22.0%
Q2 24
17.6%
Q1 24
13.5%
营业利润率
CBFV
CBFV
RMTI
RMTI
Q4 25
38.1%
-2.2%
Q3 25
-289.8%
-9.9%
Q2 25
35.0%
-8.4%
Q1 25
19.3%
-7.2%
Q4 24
23.1%
-2.1%
Q3 24
31.2%
6.8%
Q2 24
26.4%
2.0%
Q1 24
37.9%
-5.8%
净利率
CBFV
CBFV
RMTI
RMTI
Q4 25
-3.0%
Q3 25
-235.2%
-11.0%
Q2 25
29.3%
-9.3%
Q1 25
15.8%
-8.0%
Q4 24
-3.1%
Q3 24
25.3%
5.9%
Q2 24
21.8%
1.3%
Q1 24
31.1%
-7.6%
每股收益(稀释后)
CBFV
CBFV
RMTI
RMTI
Q4 25
$0.90
$-0.01
Q3 25
$-1.07
$-0.05
Q2 25
$0.74
$-0.05
Q1 25
$0.35
$-0.04
Q4 24
$0.45
$-0.02
Q3 24
$0.60
$0.04
Q2 24
$0.51
$0.01
Q1 24
$0.82
$-0.06

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
CBFV
CBFV
RMTI
RMTI
现金及短期投资手头流动性
$31.7M
$10.7M
总债务越低越好
股东权益账面价值
$157.5M
$37.0M
总资产
$1.5B
$57.1M
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
CBFV
CBFV
RMTI
RMTI
Q4 25
$31.7M
$10.7M
Q3 25
$55.9M
$13.6M
Q2 25
$64.5M
$12.5M
Q1 25
$61.3M
$11.4M
Q4 24
$49.6M
$15.7M
Q3 24
$147.3M
$12.3M
Q2 24
$142.6M
$11.9M
Q1 24
$73.7M
$6.6M
股东权益
CBFV
CBFV
RMTI
RMTI
Q4 25
$157.5M
$37.0M
Q3 25
$152.5M
$37.0M
Q2 25
$148.4M
$30.4M
Q1 25
$148.3M
$31.5M
Q4 24
$147.4M
$32.6M
Q3 24
$149.1M
$29.1M
Q2 24
$142.9M
$23.5M
Q1 24
$141.6M
$20.6M
总资产
CBFV
CBFV
RMTI
RMTI
Q4 25
$1.5B
$57.1M
Q3 25
$1.5B
$57.5M
Q2 25
$1.5B
$52.6M
Q1 25
$1.5B
$54.0M
Q4 24
$1.5B
$59.2M
Q3 24
$1.6B
$57.1M
Q2 24
$1.6B
$53.0M
Q1 24
$1.5B
$50.7M

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
CBFV
CBFV
RMTI
RMTI
经营现金流最新季度
$17.8M
$2.3M
自由现金流经营现金流 - 资本支出
$17.2M
$2.2M
自由现金流率自由现金流/营收
124.1%
12.0%
资本支出强度资本支出/营收
4.7%
0.5%
现金转化率经营现金流/净利润
过去12个月自由现金流最近4个季度
$29.5M
$-1.2M

8季度趋势,按日历期对齐

经营现金流
CBFV
CBFV
RMTI
RMTI
Q4 25
$17.8M
$2.3M
Q3 25
$4.6M
$-1.3M
Q2 25
$4.1M
$1.8M
Q1 25
$4.0M
$-3.5M
Q4 24
$6.8M
$865.0K
Q3 24
$3.1M
$4.3M
Q2 24
$-1.2M
$1.4M
Q1 24
$3.3M
$-2.4M
自由现金流
CBFV
CBFV
RMTI
RMTI
Q4 25
$17.2M
$2.2M
Q3 25
$4.5M
$-1.5M
Q2 25
$3.9M
$1.7M
Q1 25
$3.9M
$-3.5M
Q4 24
$3.4M
$470.0K
Q3 24
$2.2M
$4.1M
Q2 24
$-2.4M
$1.2M
Q1 24
$2.3M
$-2.5M
自由现金流率
CBFV
CBFV
RMTI
RMTI
Q4 25
124.1%
12.0%
Q3 25
186.5%
-9.6%
Q2 25
28.8%
10.5%
Q1 25
32.5%
-18.8%
Q4 24
26.0%
1.9%
Q3 24
17.4%
14.4%
Q2 24
-19.6%
4.5%
Q1 24
17.0%
-11.1%
资本支出强度
CBFV
CBFV
RMTI
RMTI
Q4 25
4.7%
0.5%
Q3 25
4.3%
1.4%
Q2 25
1.9%
1.0%
Q1 25
0.8%
0.3%
Q4 24
25.1%
1.6%
Q3 24
6.7%
0.7%
Q2 24
10.0%
1.1%
Q1 24
7.2%
0.6%
现金转化率
CBFV
CBFV
RMTI
RMTI
Q4 25
Q3 25
Q2 25
1.05×
Q1 25
2.11×
Q4 24
Q3 24
0.95×
2.57×
Q2 24
-0.44×
4.20×
Q1 24
0.78×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

CBFV
CBFV

暂无分部数据

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

相关对比